Translation Myths, AI Lies, and the Billion-Dollar Blind Spot in Clinical Research

AI Can Translate Everything… Right? Duncan Shaw Explains Why That Thinking Could Cost You Millions

We’re living in a world where automation gets all the applause. But in clinical research, one mistranslation can derail a trial—or worse, jeopardize patient safety.

In this episode of the TMF Daily Podcast, we sit down with Duncan Shaw, President and Owner of DTS Language Services, a leader in high-accuracy translation for life sciences with over 50 years of industry experience. Duncan is here to debunk the myths, challenge the AI hype, and share what really goes into producing regulatory-grade translations that sponsors, CROs, and IRBs can trust.

This conversation is for anyone managing global trials, working with multilingual protocols, or being sold the dream of “AI can do it all.” You’ll walk away with practical insight, powerful principles, and a deeper respect for the human expertise that still drives quality in clinical research.

 In this episode, we cover:

• The #1 translation risk most sponsors overlook

• Why accuracy is a non-negotiable in high-stakes trials

• How DTS delivers speed and precision without compromise

• Real-world examples of translation failures—and how to avoid them

👉 Subscribe for more conversations that keep your TMF audit-ready and your clinical operations sharp.

#clinicalresearch #TMF #translations #lifeSciences #GCP #AIinHealthcare #trialmasterfile #clinicalresearchcareers